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Toxoplasma gondii infection remains a condition of interest in both human and 
veterinary medicine despite having recently celebrated its first century of recognition.  
Toxoplasma is distinguished from intestinal coccidia in its utilization of intermediate 
hosts, causing disease in a wide spectrum of animals.  Diagnosis is also more 
complicated as it localizes in numerous tissues in intermediate hosts and has only a 
brief period of oocyst shedding in infected felids.  The inability to diagnose Toxoplasma 
infection by direct observation has led to a reliance on serological assays as the primary 
diagnostic method.  Serological testing establishes a history of exposure to 
Toxoplasma, but does not definitively identify this as the genesis of the clinical signs of 
interest.  The situation is more complicated in veterinary medicine by the decreasing 
availability of test methods that can be used across the range of animals susceptible to 
infection.   
The development of protein conjugates A, G and chimeric A/G allows the use of 
a human enzyme-linked immunosorbent assay for a range of animal species.  When 
compared to established agglutination testing for the detection of anti-Toxoplasma IgG 
antibody, agreement between the two tests was determined to be very good, with a 
kappa value of 0.83 for the trial using proteins A and G separately and 0.81 when 
 
 
chimeric protein A/G was used.  This technique demonstrated a seropositivity of 38.5% 
when utilized to examine the occurrence of Toxoplasma exposure among hunter-killed 
white-tailed deer in New York State from 2010, indicating a notable level of exposure in 
this population.  Further analysis revealed older deer are more likely to have 
seroconverted, consistent with a model of significant horizontal transmission by oocysts.  
No significant differences in infection based on sex or local human population density 
were noted.  A quantitative real-time PCR assay was developed based on the 
Toxoplasma B1 gene, but did not detect the presence of parasite DNA in serum 
samples from seropositive dogs and sheep.  These ELISA and PCR assays are 
valuable both to veterinary diagnosticians in individual cases and to investigators 
studying Toxoplasma prevalence in a broad spectrum of domestic and wild animals.
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CHAPTER ONE 
INTRODUCTION 
Toxoplasmosis is a significant disease in humans and many other animal species 
and is caused by the invasion of tissue by the apicomplexan Toxoplasma gondii.  While 
the systematic description of the organism is rather straightforward, namely being the 
only representative of the genus Toxoplasma and the small family Toxoplasmatidae in 
the order Eimeriorina, there are not many other facets of Toxoplasma and 
toxoplasmosis that are so easily characterized (Dubey, 2010).  This has contributed to 
both an intense research and public interest in the organism and its associated disease, 
and the generation of misunderstanding and misplaced concern in the medical and 
veterinary communities.  A singular aspect of the parasite’s life cycle that is well 
understood is the importance of domestic and wild felids in the perpetuation of 
Toxoplasma as the only known definitive hosts.  Beyond that, the ability of the organism 
to be transmitted both vertically and horizontally, infecting new hosts through ingestion 
of tissue cysts in intermediate hosts, oocysts in contaminated soil, water and produce, 
and from congenital transmission, makes a simple portrayal of the typical Toxoplasma 
life cycle a fleeting generality.  Much of the interest in toxoplasmosis relates to the 
severity of disease in human fetuses and immunosuppressed populations (Lindsay et 
al., 2003).  Though only an estimated 15% of human infections with Toxoplasma result 
in detectable clinical signs, it is the third leading cause of death from foodborne disease 
in the United States (Mead et al., 1999), hinting at the prevalence of infection in this 
population.  Understanding the behavior of Toxoplasma in human populations gives a 
woefully incomplete picture of the parasite.  Since it is a zoonotic disease, medical and 
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veterinary investigations should be intimately linked to produce reasonable control 
strategies.  This study describes the creation and testing of new diagnostic strategies to 
assist veterinary investigators in their understanding of the role of Toxoplasma infection 
in their patients, and thereby contributes to efforts to combat its further perpetuation. 
HISTORY 
The history of Toxoplasma gondii discovery, identification of hosts, description of 
its life cycle, diagnostic strategies and treatment have been thoroughly reviewed (Dubey 
2008; Dubey 2010; Ferguson, 2009), however a summary is warranted to distill the 
pertinent literature that influenced the current investigation.  Two investigative teams in 
the early 20th century noted the presence of protozoal organisms in their research 
gundy (Ctendactylus gundi) in Tunisia and rabbits (Oryctolagus cuniculus) in Brazil, and 
both initially attributed the observation to Leishmania sp., before the former group 
realized it was an undescribed species and the former group named it Toxoplasma 
gondii (sic?) (Nicolle and Manceaux, 1909; Splendore, 1908).  One year later, a clinical 
case of toxoplasmosis was described in the domestic dog (Canis familiaris) in Italy, an 
early insight into the distribution of this parasite across divergent animal species and 
geographic areas (Mello, 1910).  Tissue cyst structures were first noted by a group in 
rabbits and mice and described cytologically about 20 years after the organism’s initial 
identification (Levaditi et al., 1928).  Early investigators depended on thorough 
microscopic work and staining techniques. The advent of serological tests and 
molecular diagnostic techniques led to a rapidly increased understanding of the parasite 
and its role in clinical disease. 
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Human Toxoplasmosis 
Toxoplasmosis was established as a disease of humans by the observation of a 
case of congenital transmission in 1939 and infectiousness to animals from this case 
was demonstrated (Ferguson, 2009; Wolf et al., 1939).  The recognition of the potential 
importance of Toxoplasma infection in human health precipitated development of 
diagnostic tests to allow antemortem detection.  Sabin and Feldman recognized that 
Toxoplasma tachyzoites lose their affinity for methylene blue in the presence of anti-
Toxoplasma antibody, leading to the description of the first widely used serological test, 
the Sabin-Feldman dye test (Dubey, 2008; Sabin and Feldman, 1948).  Though still 
considered a gold standard in serological testing, the requirement for live parasites 
limits the utility of the test, both due to the difficulty of acquiring and storing the 
organism, and potential risk to laboratory personnel.  Multiple tests have since been 
developed that observe the agglutination of killed parasite or particles coated with 
antigen in the presence of antibody as the basis of serological diagnosis, including the 
direct agglutination test, the modified agglutination test, indirect hemagglutination and 
latex agglutination (Desmonts and Remington, 1980; Dubey and Desmonts, 1987).  
These have the advantages of not using live organism, but still being able to test human 
and animal sera equally well, due to lack of reliance on a species-specific protein 
conjugate for detection.  A disadvantage is their reliance on subjective interpretation by 
the user as to a positive or negative reaction.  The reliance on serological interpretation 
in the diagnosis of toxoplasmosis leads to difficulties for medical and veterinary 
clinicians in judging the significance of a positive test, i.e., is the presence of antibody 
indicative of a clinically significant infection or just a historical artifact of an old infection?  
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The advent of techniques to establish the presence of live organism in different tissues 
holds promise in providing more information, with a polymerase chain reaction 
technique targeting Toxoplasma first being described over two decades ago (Burg et al., 
1989).   
Feline Toxoplasmosis 
Feline toxoplasmosis was first diagnosed in a domestic cat (Felis catus) from 
Middletown, NY, in 1942 (Dubey 2008; Olafson and Monlux, 1942). The protracted time 
between initial description (1908) and this first described case in what was later 
determined to be the most significant definitive host of the organism is a tribute to the 
covert nature of Toxoplasma transmission and symptomatology in this host.  It was 
another two decades before an investigator noted that Toxoplasma oocysts can be 
isolated from feline feces (Hutchison, 1965). He further noted that they can remain 
infectious in the environment for at least 12 months as demonstrated by experimental 
transmission to mice.  Feline intestinal stages, both sexual and asexual, were described 
in detail by Frenkel and Dubey, (Frenkel et al., 1970).  They demonstrated that domestic 
cats shed oocysts following ingestion of infected mice, and further noted a discrepancy 
in the pre-patent period for Toxoplasma in the feline host based on the stage of the 
parasite that produced the infection.  Tissue cyst ingestion, which is thought to be the 
most common method of feline infection due to predation of intermediate hosts, 
revealed shedding of oocysts in 3-5 days.  In contrast, ingestion of tachyzoites 
produced oocyst shedding in 8-10 days and ingestion of oocysts produced shedding in 
21-24 days.  Though oocyst shedding is intensive, with one study noting up to 13 million 
oocysts per gram of feces, it is temporally abbreviated, at approximately one week 
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(Dubey 2010; Schares et al., 2008).  This unfortunately makes direct fecal examination 
a diagnostic test of very low sensitivity even in the definitive host, and questionable 
specificity due to the similar appearance of other protozoan oocysts like Hammondia 
hammondi. 
Toxoplasma in Intermediate Hosts 
The search for intermediate hosts for Toxoplasma gondii has been accomplished 
by numerous investigators with notable success (Dubey, 2010).  Current evidence 
indicates that any warm-blooded animal can serve as an intermediate host for the 
organism, and the identification of marine invertebrates as a source of infection 
significantly broadens the number of animals of potential interest (Lindsay et al., 2004).  
The earliest animals identified as intermediate hosts of Toxoplasma gondii were the 
gundy, rabbit, domestic dog and mouse (Levaditi et al., 1928; Mello 1910; Nicolle and 
Manceaux, 1909; Splendore, 1908).  The first isolation of viable Toxoplasma was from 
laboratory mice and led to its characterization as an obligate intracellular parasite 
(Sabin and Olitsky, 1937).  The lack of a requirement for a definitive host in the 
parasite’s propagation was noted by oral infection of pigs with mouse tissue, and of 
mice with pork, also establishing the potential risk to humans from meat consumption 
(Weinman and Chandler, 1954).  Similarly, minced fetal cotyledons from suspected 
ovine abortion cases were demonstrated to be infectious to other pregnant ewes and 
mice by intraperitoneal injection (Hartley and Marshall, 1957).  More recently, the 
surprising finding of toxoplasmosis being a cause of significant mortality in southern sea 
otters (Enhydra lutris nereis) demonstrated how pervasive environmental contamination 
with Toxoplasma oocysts is in both terrestrial and marine environments (Cole et al., 
6 
 
2000).  The ability of Toxoplasma to infect a wide host range and to have a broad 
geographic distribution (described from all continents) makes it one of the most 
common protozoal parasites in the world. 
 
LIFE CYCLE 
The demonstration of successful Toxoplasma transmission by congenital, 
carnivorous and fecal-oral routes stimulated research interest into the parasite’s life 
strategy that allows survival in widely diverse hosts (Dubey et al., 2008; Frenkel et al., 
1970; Hutchison, 1965; Weinman and Chandler, 1954).  In intermediate hosts, 
sporozoites released from sporocysts penetrate through intestinal epithelial cells and 
migrate to the lamina propria, where numerous different types of cells are invaded, and 
two tachyzoites are produced by approximately 12 hours post infection.  Following 
invasion of additional tissues with tachyzoites, tissue cysts have been noted to start 
forming by 6 days post infection and these likely persist for the life of the animal.  The 
life cycle in felids can follow this same course, making felids uniquely both potential 
intermediate and definitive hosts.  The latter due to their hosting the sexual stages of 
Toxoplasma, in which schizogony is noted after intestinal invasion, leading to the 
production of sexual stages (female macrogamonts and male microgamonts) by 2 days 
after infection.  Following the formation of zygotes and oocyst walls, the host cell 
ruptures, discharging oocysts into the intestine (Dubey, 2010).  Both life cycles require 
an evasion of the host’s immune system to proceed successfully, and the same white 
blood cells that respond to the presence of the parasite are utilized to spread infection 
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throughout the host (Denkers et al., 2012).  The prepatent period between oral ingestion 
and shedding of oocysts in domestic cats varies depending on the stage of the parasite 
initiating infection as noted above (Frenkel et al., 1970).  Considering the abbreviated 
prepatent period following tissue cyst ingestion in the cat with the similarly brief time 
from oral ingestion to tissue cyst production in intermediate hosts, it is easy to surmise 
how quickly contamination can spread through a felid-intermediate host/prey 
ecosystem, e.g. felids and rodents. 
 
PUBLIC HEALTH  
Mortality due to Toxoplasma infection in humans occurs in very few cases, most 
notably due to reactive encephalitis in immunocompromised patients and abortion in 
naïve mothers on first exposure (Dabritz and Conrad, 2010).  However, morbidity due to 
toxoplasmosis can take many forms, related to the diverse tissue types that can be 
invaded in intermediate hosts.  The prevalence of infection in humans varies widely, 
with a seroprevalence of 38% noted in the United States and a range of 4-92% noted in 
other countries. The fecundity of oocyst production (an average of 10,000,000 oocysts 
shed per infected cat has been estimated) and their environmental durability, with 
survival times of greater than one year noted in both natural and experimental setting, 
contribute to the common nature of the infection (Dubey, 2010).  However, in a large 
European study, contact with domestic cats was not identified as a risk factor for 
seropositivity.  Rather, eating undercooked meat, contact with soil and travel outside of 
Europe, the United States and Canada were significant.  In all, 30-63% of infections 
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were attributed to consumption of undercooked or cured meat and 6-17% of infections 
related to soil contact (Cook et al., 2000).  It should be noted that this is not necessarily 
conclusive, and a significant prevalence in people who don’t consume meat indicates 
that not only oocyst contact through soil, but consumption of contaminated water, fruits 
and vegetables can be risk factors.  Methods to reduce human exposure include:  
proper cooking of meat and vegetables, hand hygiene after handling meat or having soil 
contact, preventing predation by owned cats, providing litter boxes and controlling feral 
cat populations (Dabritz and Conrad, 2010).  Unfortunately, even given promotion of 
these control measures in human and domestic animal populations, the recognition of 
Toxoplasma strains in wildlife capable of infecting humans implies a sylvatic life cycle 
that can independently perpetuate the parasite’s population (Dubey et al., 2008; Wendte 
et al., 2011). 
 
ANIMAL HEALTH  
The occurrence of Toxoplasma infection in domestic cats is a topic of interest 
primarily due to the threat their infection poses to humans and other animals, as clinical 
signs in the felid host are typically inapparent.  An extensive survey of cats that were 
clinically ill from any cause in the United States found a seroprevalence of 31.6% 
overall, with the southwestern US having the lowest prevalence (16.1%) and the 
northeastern US having the highest prevalence (43.5%).  Significant factors other than 
geographic location that predisposed the cats to being positive were:  older age, being 
male and being a domestic short-haired breed (Vollaire et al., 2005).  A study of Ohio 
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cats brought into a mobile spay and neuter clinic revealed a 48% overall seropositivity, 
with a 62% prevalence noted in owner described outdoor cats (Dubey et al., 2002).  A 
survey of Pennsylvania cats from a periurban environment yielded a significantly lower 
seropositivity of 19.5% (Dubey et al., 2009).  In the United States, the range of 
seropositivity survey results for cats was a low of 12.1% from Florida and a high of 80% 
from Iowa (Hill et al., 1998; Luria et al., 2004).  Surveys from other countries produced a 
wider range of seroprevalences, from a low of 2.1% in a Chinese study to a high of 
89.3% in a Colombian study (Dubey 2010; Shen et al., 1990).  A survey of non-
domestic felines in the United States found a prevalence of 43.6%, looking at both 
captive and free-ranging animals (Spencer et al., 2003). The degree of exposure to 
Toxoplasma for both domestic and wild felids as demonstrated by these studies is 
significant from diverse geographic and demographic areas. 
It is noted that the description of Toxoplasma infection in the domestic dog 
preceded that in the domestic cat by more than three decades (Mello, 1910; Olafson 
and Monlux, 1942).  While the evaluation of the significance of toxoplasmosis in the dog 
is somewhat complicated by the potential of infection with Neospora caninum, it is clear 
that both can be significant diseases in the dog.  An examination of stray dogs and cats 
in Sao Paulo, Brazil, revealed a seroprevalence of 40% in cats and 50.5% in dogs, 
which the authors attributed to the more selective palate of cats (Meireles et al., 2004). 
A demonstration of the broad appetite of dogs was the identification of viable 
Toxoplasma oocysts in canine feces in a German study, which could have wrongly 
indicted dogs as an alternative definitive host if the investigators weren’t familiar with 
their coprophagic habits (Schares et al., 2005).  A study of stray animals in Bangkok, 
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Thailand, revealed significantly lower levels of seroconversion than many studies, 11% 
in cats and 9.4% in dogs, the authors noted that this population of animals were often 
fed cooked fish and rice by local monks, foods that would be expected to carry a low 
risk of serving as routes of infection (Jittapalapong et al., 2007).  A study in the United 
States revealed a seroprevalence of 25% in Kansas dogs, with a range of 5.2-88.5% 
noted in other areas of the world, the lowest value noted from urban, owned dogs in 
Brazil and the highest value from dogs in Mato Grosso, the Brazilian state with the 
lowest human population density (deSouza et al., 2003; Lindsay et al., 1990; Santos et 
al., 2009; Wikipedia, 2013).  Domestic dogs, especially free living dogs that are more 
likely to participate in predation, can serve as a good sentinel for local Toxoplasma 
population, as they can be expected to be exposed both through oocyst and tissue cyst 
ingestion (Meireles et al., 2004). 
There is interest in Toxoplasma infection in food animals, both due to potential 
public health risk from meat and milk consumption and economic losses due to disease.  
One of the earliest demonstrations of the importance of toxoplasmosis in sheep 
production was an investigation of an abortion storm on a farm in New Zealand, in 
which minced cotyledons from infected ewes transmitted Toxoplasma to both additional 
ewes and mice (Hartley and Marshall, 1957).  A similar outbreak in New York revealed 
that 73.8% of sheep on the farm were seropositive for Toxoplasma exposure (Dubey 
and Welcome, 1988).  The range of seroprevalences in studies of sheep in the United 
States is 27.1-73.8%, with a range of 3-95.7% noted from sheep studies worldwide 
(Dubey 2010; Dubey et al., 2008; Zaki, 1995).  Similar clinical effects have been noted 
in caprine toxoplasmosis, with US surveys noting a seroprevalence of 22.1-51.9% in 
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goatherds, and a worldwide seroprevalence of 3.2-90.9% (Dubey 2010; Dubey and 
Adams, 1990; Garcia-Vazques et al., 1993; McSporran et al., 1985; Patton et al., 1990).  
Consumption of poorly cooked lamb and goat should be considered a significant route 
to Toxoplasma exposure.  Pork may also be a significant source of Toxoplasma, as 
reported in a Massachusetts study in which 51 of 55 pigs destined for human 
consumption were found to have viable tissue cysts in their heart and tongue tissue 
(Dubey et al., 2002).   
Toxoplasmosis is not considered a pathogen of significant concern in cattle and 
horses, though both can experience infection.  These infections tend to be insignificant 
in both intensity and duration with misdiagnosis due to infections with Neospora spp. 
and Sarcocystis spp. (Dubey, 2010; Dubey and Desmonts, 1987).  Many wildlife 
species, however, are both susceptible to Toxoplasma infection and clinical 
toxoplasmosis.  One species of interest as a sentinel host for domestic herbivores is the 
white-tailed deer (Odocoileus virginianus), both due to its tendency to graze alongside 
livestock and its wide dispersal.  A study in Ohio noted a seroprevalence of 44% among 
white-tailed deer, 6% in deer harvested in urban parks (Columbus) and 55% in more 
rural Hocking County.  This implies that human (and by extension domestic cat) 
population density is not the only predictor of environmental contamination by 
Toxoplasma (Crist et al., 1999).  This question is revisited in the serosurvey of New 
York deer described below.  A higher seroprevalence (60%) was noted in hunter-killed 
deer in Pennsylvania, with surveys in other states ranging from 30-64.2% (Dubey, 2010; 
Dubey et al., 2009; Humphreys et al., 1995; Vanek et al., 1996).  The clinical effect of 
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Toxoplasma infection on deer is poorly understood, as is the question of bias arising 
from an interaction between infection and the tendency to be killed by hunters. 
 
DIAGNOSTIC TEST DEVELOPMENT 
The discovery and subsequent investigation of Toxoplasma gondii largely 
depended on bioassays and microscopic examination until the advent of the Sabin-
Feldman dye test, which allowed highly accurate antemortem diagnosis of Toxoplasma 
exposure through the evaluation of serum samples (Sabin and Feldman, 1948).  The 
dye test proved highly sensitive and accurate, but had the distinct disadvantage of 
having the requirement for live Toxoplasma tachyzoites, a potential risk to laboratory 
staff conducting the test (Reiter-Owona et al., 1999).  In medical diagnostics, a number 
of immunofluorescence and enzyme-linked immunosorbent assays (ELISA) were 
developed but have limited utility in veterinary diagnostics due to their requirement for 
species-specific protein conjugate.  The development of the direct agglutination and 
later the modified agglutination tests, techniques that utilized formalin-killed rather than 
live tachyzoites and did not have a conjugate requirement was revolutionary in the 
diagnosis and investigation of toxoplasmosis in animals (Desmonts and Remington, 
1980; Dubey and Desmonts, 1987).  These techniques have been further modified to 
produce additional agglutination tests that utilize the same strategy: the indirect 
hemagglutination test using antigen coated sheep red blood cells and the latex 
agglutination test using antigen coated latex beads.  Indirect hemagglutination test 
results were noted to agree with Sabin-Feldman dye test results in human patients, and 
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similarly remain positive for life (Lunde, 1973).  In a study of experimental infection 
using cats that were monitored for up to 950 days after inoculation, the Sabin-Feldman 
dye test, modified agglutination test (MAT), indirect hemagglutination test (IHA) and 
latex agglutination test (LAT) were compared and the MAT was found to be the most 
sensitive of the agglutination methods (Dubey and Thulliez, 1989).  The MAT and IHA 
were found to produce similar results in a study of dairy goats (Patton et al., 1990).  The 
MAT also had good correlation with an ELISA test developed specifically for porcine 
testing (Gamble et al., 2005).  None of the agglutination tests reliably detect IgM on 
known IgM positive samples, and therefore become positive later in the course of 
infection than the dye test (Lappin and Powell, 1991).  Agglutination testing remains the 
most commonly used modality for the diagnosis of toxoplasmosis in animals, despite 
the loss of availability of some commercial kits. 
Diagnosis of Toxoplasma infection in humans is largely accomplished by 
serological investigation using IgG and IgM ELISAs, as the requirement for species-
specific conjugate is not as burdensome as in veterinary medicine.  There are 
numerous commercial serological tests available for the detection of Toxoplasma 
exposure in humans, one study compared three ELISAs, two IHAs, one IFA and one 
LAT to the Center for Disease Control’s reference indirect immunofluorescence test and 
found 100% sensitivity across the tests, with a range of specificities from 77.8-100%, 
and perfect agreement being noted by one representative of each testing method 
(Wilson et al., 1987).  The reliance on a single serum test (e.g. IgM ELISA) to determine 
the critical question of chronicity of infection, however, complicates the diagnostic 
picture, as false positives indicating acute infection can have dramatic consequences in 
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the management of patients, especially pregnant women.  Several studies have noted 
high sensitivities but variable specificities for commercial IgM ELISAs, with a positive 
predictive value of only 43.3% noted in one (Kodym et al., 2006; Roberts et al., 2001; 
Wilson et al., 1997).  Confirmation testing must be an absolute requirement in these 
cases, two options being paired IgG testing or IgG avidity testing (Liesenfeld et al., 
1997). While few IgM ELISAs are utilized for veterinary diagnostics, IgM testing can be 
accomplished by utilizing modified agglutination methods, but the same cautions must 
be noted when relying on a single serum sample for the determination of infection 
chronicity. 
In veterinary diagnostic investigation for Toxoplasma, the production of 
recombinant antigen and advance of molecular techniques has expanded diagnostic 
options, while more established agglutination techniques are becoming less 
commercially available.  Some species specific ELISAs have been developed and 
performed well when compared to reference serological techniques, notably for cats, 
sheep and pigs (Dabritz et al., 2007; Hill et al., 2006; Kimbita et al., 2001; Klun et al., 
2007; Mainar-Jaime and Barberan, 2007; Shaapan et al., 2008).  Some cautions that 
must be noted in interpretation of these results include the potential of cross-reactivity in 
the presence of infections with other coccidia and the difficulty of determining true 
sensitivities and specificities without a reliable gold standard for comparison (Gardner et 
al., 2009; Silva et al., 2002).  A notable weakness for these ELISA procedures is their 
requirement for species-specific conjugates, which appears to require a large number of 
individual ELISAs to test the range of animal serum submitted to veterinary diagnostic 
laboratories, making them a poor replacement for the established agglutination 
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techniques.  Some investigators have examined the use of non-species specific protein 
conjugates in veterinary diagnostic testing, e.g. proteins A, G and A/G, with some 
success (Bhide et al., 2004; Eliasson et al., 1989; Werre et al., 2002; Zhang et al., 
2010), and this technique is developed further as described below.  While serological 
detection is the primary mode of Toxoplasma diagnosis, molecular techniques are 
increasingly being used, since the first identification of a gene target for polymerase 
chain reaction amplification (Burg et al., 1989).  PCR is now commonly used to test 
amniotic fluid in pregnant women with suggestive serological results, and has been 
used for environmental detection of oocysts and characterization of Toxoplasma 
genotypes in vertebrate hosts (Schwab and McDevitt, 2003; Su et al., 2006).  The 
difficulty of acquiring the appropriate tissue sample for antemortem diagnosis makes 
PCR a modality of questionable sensitivity but potentially excellent specificity when 
used in the diagnostic setting, a question which is further examined below. 
 
SPECIFIC AIMS 
Numerous commercially produced diagnostic kits are available for evaluation of human 
serum for evidence of Toxoplasma exposure.  A human IgG ELISA kit was modified by 
the use of either protein A, protein G or protein A/G chimeric conjugate to replace the 
goat anti-human IgG protein conjugate supplied with the kit to allow evaluation of 
nonhuman animal sera.  These ELISAs were compared to previous results generated 
by a commercially produced agglutination test (IHA) using catalogued sera previously 
submitted to the New York Animal Health Diagnostic Center for Toxoplasma testing.  
16 
 
Traditional and real time PCR assays were developed based on the B1 gene sequence 
and sensitivities of both were tested using cultured tachyzoites.  These assays were 
then used to test sera with known anti-Toxoplasma IgG for the presence of Toxoplasma 
DNA.  The modified protein A/G conjugate ELISA was used to detect seroconversion in 
a population of New York State hunter-killed white-tailed deer. 
 
1. Determine efficacy of replacement of protein A or protein G conjugate in 
human serologic kit in testing for Toxoplasma 
2. Test replacement of kit conjugate with chimeric protein A/G conjugate to 
establish a single test for animal diagnostics 
3. Determine the most sensitive primer in PCR detection of Toxoplasma DNA 
and demonstrate minimum detectable copy number by both traditional and real 
time PCR 
4. Describe risk factors for Toxoplasma exposure in a retrospective case-control 
study of New York State hunter-killed deer 
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CHAPTER TWO 
 
MODIFICATION OF A COMMERCIAL TOXOPLASMA GONDII IMMUNOGLOBULIN 
G ENZYME-LINKED IMMUNOSORBENT ASSAY FOR USE IN MULTIPLE ANIMAL 
SPECIES 
 
ABSTRACT 
A challenge faced by veterinary diagnosticians in serologic analysis for exposure 
to pathogens is the need for protein conjugate capable of antibody attachment in many 
animal species. The advent of protein conjugates that are less specific in nature allows 
diagnosis across many species with little or no modification of technique. Toxoplasma 
gondii is an organism of veterinary interest that has been demonstrated to infect a 
plethora of warm-blooded animals. However, the serologic tests available for 
simultaneous diagnosis in this broad range are limited in number.  The current study 
examined the use of an immunoglobulin G enzyme-linked immunosorbent assay 
(ELISA) modified by the use of non-species-specific protein conjugates in domestic 
animal species commonly submitted to diagnostic laboratories for evaluation of 
Toxoplasma exposure status. Comparison to results from an established indirect 
hemagglutination technique revealed very good agreement between the 2 test methods. 
This modification of the ELISA provides a useful method for veterinary diagnosticians to 
perform rapid and accurate evaluation of multiple animal species for Toxoplasma 
exposure using a single test. 
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INTRODUCTION 
Toxoplasma gondii is a protozoal organism that can cause clinical disease in 
both definitive and intermediate hosts and is believed to be one of the most common 
parasitic infections in the world (Kijlstra et al., 2004). Toxoplasmosis has been 
described from human beings and numerous wild and domestic animals, including 
birds, canids, felids, rodents, and ruminants (Lindsey and Dubey, 2007). The risk of 
congenital transmission with potentially severe consequences for the fetus in acutely 
infected pregnant women has generated great public interest in this organism, as has 
emerging recognition of its importance in causing disease in immunocompromised 
patients (Montoya and Liesenfeld, 2004). In France, concern about congenital 
toxoplasmosis is such that pregnant women are tested monthly to detect the presence 
of recent infection (Remington et al., 2004). Felids have been demonstrated to be the 
definitive host for the organism, while a great diversity of vertebrates, including human 
beings and many domestic and wild animals, have been found to be intermediate hosts. 
Infection of the definitive felid host can be acquired through predation or 
scavenging of meat from an infected intermediate host via tissue cysts, by ingestion of 
oocysts shed by an infected felid, or by congenital transmission from an infected queen. 
Infection is established in the intestinal tract where asexual and sexual reproduction 
takes place, leading to fecal shedding of oocysts, potentially accompanied by more 
generalized infection. Intermediate hosts can similarly be infected by either ingestion of 
oocysts or tissue cysts. In intermediate and dead-end hosts, sporozoites from ingested 
oocysts or bradyzoites from ingested tissue cysts enter the wall of the small intestine. 
Tachyzoite development leads to systemic spread and invasion of numerous organs 
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where bradyzoite-containing tissue cyst development proceeds (Dubey, 2004; Ferguson 
and Dubremetz, 2007; Mucker et al., 2006; Speer and Dubey, 1998). The complexity of 
the life cycle of Toxoplasma and the relatively short period of oocyst shedding from the 
definitive host has led to the development of numerous serologic techniques to 
diagnose infection. The ideal serologic test for diagnosis in the veterinary setting is 
objective, has high throughput potential, and demonstrates both high sensitivity and 
specificity in numerous species. 
Clinical signs in definitive and intermediate hosts due to infection with 
Toxoplasma vary in severity from negligible to terminal disease. A great deal of concern 
in both human and animal health involves the risk of abortions and fetal malformations 
in the presence of acute infection. Among domestic animals, abortion in sheep and 
goats is widely noted, while significance in cattle is less well defined, likely due to the 
similarity to manifestation of Neospora caninum infection (Dubey and Lindsay, 1996). 
Most cats are believed to remain asymptomatic upon initial infection, though some 
display nonspecific signs such as fever, dyspnea, and abdominal pain (Dubey and 
Carpenter, 1993). Space-occupying lesions created by enlarging tissue cysts can 
produce disease, related to their site of localization in the vertebrate intermediate host, 
notably causing neurologic and/or ocular deficits. 
The relatively brief period of oocyst shedding in the definitive felid host, combined 
with the persistent immunoglobulin G (IgG) antibody response in both definitive and 
intermediate host infections, make serologic evaluation the method of choice for 
detecting exposure to Toxoplasma in all potential host species (Dabritz and Conrad, 
2010; Dabritz et al., 2007; Dubey, 1995; Dubey, 2001; Dubey, 2004; Dubey et al., 
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1977).  Techniques that have been commonly used include the Sabin–Feldman dye 
test, latex agglutination, hemagglutination assays, fluorescent antibody tests (FATs) and 
enzyme-linked immunosorbent assays (ELISAs). Some of these are hampered in the 
veterinary diagnostic environment by the use of live organism (Sabin–Feldman) or by 
the requirement for species-specific conjugate (FAT and ELISA). In the current study, 
the results of a commercially produced indirect hemagglutination assay were compared 
with those of a commercially available IgG ELISA, modified to detect IgG antibody in 
multiple animal species. 
 
MATERIALS AND METHODS 
Animals and samples 
Blood samples were collected from animals by referring veterinarians into clot 
tubes. The extracted serum samples were submitted to the Animal Health Diagnostic 
Center at Cornell University (Ithaca, New York) from 2001 to 2008 for detection of 
Toxoplasma exposure by indirect hemagglutination. After storage at 5ºC, positive 
samples with a sufficient amount of serum remaining and a sampling of negative 
samples were reassessed using the modified IgG ELISA technique in 2008–2009. The 
sera tested included samples from 46 alpacas, 26 cats, 53 dogs, 39 goats, 21 horses, 
and 42 sheep. 
Indirect hemagglutination assay 
Seroreactivity to Toxoplasma antigens was initially evaluated using an indirect 
hemagglutination assay (IHA).a  The commercial preparation of the IHA had perfect 
qualitative agreement with the Center for Disease Control and Prevention (CDC) 
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Toxoplasma indirect FAT in their evaluation of human serum samples (Wilson et al., 
1987). Serum containing anti-Toxoplasma IgG antibody causes agglutination of the 
sheep red blood cells coated with antigen as part of the test procedure (Chordi et al., 
1964; Jacobs and Lunde, 1957). The test procedure distinguishes these reactions from 
nonspecific agglutination through the use of both coated and non-coated red blood 
cells. Interpretation is based on observation of presence or absence of a red blood cell 
mat covering the bottom of the test well on completion of incubation. The test is equally 
effective for human and animal diagnostic work, as no species-specific conjugate is 
required for antibody detection (Wilson and McAuley, 1991). This procedure was used 
as a reference test to evaluate the performance of the modified IgG ELISA. 
The IHA test was prepared by adding 25 µl of sample diluent (buffered saline 
containing 0.1% sodium azide and 1% normal rabbit serum) to the bottom of as many 
U-shaped wells on a 96-well microdilution test tray as will be required and adding an 
equal volume of the liquid to be tested. Two rows were used to test the reactivity of the 
negative control (normal human serum) and 2 were used to test the reactivity of the 
positive control (anti-Toxoplasma human serum or globulin). Two rows were reserved 
for each sample to be tested. Sample diluent was tested for agglutination. The negative 
control was tested for agglutination at ratios of 1:32 and 1:64. The positive control was 
tested at ratios of 1:32 – 1:4,096 dilutions. Samples were initially screened from 1:32 to 
1:256, and were tested at higher dilutions if positive at all of these dilutions. Sheep red 
blood cells sensitized with a Toxoplasma extract were added to 1 row of each control 
and sample group. Unsensitized sheep red blood cells were added to the other row. 
The plate was shaken on a vibrating shaker briefly, and then allowed to incubate at 
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room temperature for 3 hr. A positive result was indicated by the formation of a smooth 
mat of cells covering the bottom of the well, with no such reaction noted in the 
unsensitized row. The latter reaction indicates the presence of nonspecific agglutinins, 
and invalidates the test. A negative result produces a collection of red blood cells in a 
small group in the center of the bottom of the well. Serum samples that produced 
agglutination in the 1:64 well were considered positive for anti-Toxoplasma IgG 
antibody. 
Enzyme-linked immunosorbent assay 
A commercial IgG ELISAb was modified by use of protein Ac or protein G 
conjugated to replace the conjugated goat anti-human IgG included in the kit. A similar 
method was used to create an ELISA for detection of anti-Toxoplasma antibody in 
sheep samples using protein G (Werre et al., 2002).  Samples, controls, and a calibrator 
were evaluated after dilution 1:21 with kit-supplied diluent (containing Tween-20, bovine 
serum albumin, and phosphate buffered saline). These were added to kit wells that had 
been sensitized by passive absorption with Toxoplasma antigen. Any antigen-specific 
antibody contained in the sample binds to the immobilized antigen. Protein A or G 
conjugate, depending on vertebrate species from which the sample was collected, was 
added to each well to attach to any immobilized IgG antibody. Protein A conjugate was 
used for canine and feline samples, whereas protein G conjugate was used for the 
remaining species. Following washing, microwells were then incubated with peroxidase 
substrate solution, which will change color when hydrolyzed by the presence of 
peroxidase. Color intensity of the sample indicated antibody concentration in the 
microwell. This was evaluated using a microplate reader with light at a wavelength of 
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450 nm. Comparison to kit-provided calibrators guided the identification of positive 
versus negative serum, with a ratio of sample color intensity to kit calibrator color 
intensity of greater than or equal to 1.1 indicating a positive reaction for anti–
Toxoplasma  IgG antibody as described by the kit insert. A ratio between 0.9 and 1.1 
(non-inclusive) was considered an indeterminate result, and less than or equal to 0.9 a 
negative result. 
Protein A and protein G conjugates 
Protein A and protein G horseradish peroxidase conjugates were used in the IgG 
ELISA assays instead of the kit conjugate to allow testing of multiple animal species. 
Protein A conjugates are reported to provide strong binding to antibody of cats, dogs, 
mice, pigs, and rabbits, whereas protein G conjugates are reported to provide strong 
binding to IgG antibody of cows, goats, guinea pigs, horses, mice, pigs, rabbits, and 
sheep (Eliasson et al., 1988).d Protein G conjugate also showed strong binding to 
alpaca antibody on testing with this procedure (unpublished data). Both proteins were 
received as lyophilized samples and were diluted 1:20,000 with phosphate buffered 
saline (pH 7.2) prior to use, with the dilution determined by testing against kit controls to 
satisfy quality control parameters. Similar methods have been used with these proteins 
and a chimera of the 2 proteins in previous studies (Bhide et al., 2004; Surolia et al., 
1982; Zhang et al., 2010). 
Data analysis 
The significance of association between the results of the IHA and the ELISA 
was evaluated using the McNemar Chi-square test. The degree of agreement between 
the results from the 2 tests was quantified using Kappa statistics. The accuracy of the 
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ELISA test in detecting exposure to Toxoplasma was evaluated in comparison to the 
IHA and measured using the relative sensitivity and specificity. The expected 
performance of the ELISA at different cut-off points was examined using the receiver 
operating characteristic (ROC) curves for all data and additionally separated by animal 
species. 
 
RESULTS 
Serum samples were evaluated from multiple animal species using both the IHA 
and the IgG ELISA as described. The protein G conjugate replacement was used to 
analyze alpaca, caprine, equine, and ovine sera. Protein A conjugate was used to 
analyze canine and feline sera. The sera tested included samples from 46 alpacas, 26 
cats, 53 dogs, 39 goats, 21 horses, and 42 sheep. There was no significant difference 
detected between positive versus negative results when comparing IHA and ELISA 
results with McNemar’s Chi-square (p = .07). The associated kappa value using the kit 
standard cut-off parameters was 0.83 (95% confidence interval [CI]:  0.75–0.90 
calculated using GraphPade), indicating very good agreement between the 2 test 
results. The combined sensitivity of the protein A/G modified ELISA kit was found to be 
90% (95% CI:  83–94%) and specificity 95% (95% CI:  87–98%) when the IHA results 
were utilized as a gold standard and positive versus negative ELISA results were 
determined using the manufacturer’s guidelines. It is noted that adjusting the range of 
indeterminate results to 0.8–1.0 ratios improves sensitivity based on this data to 92% 
from 90%, while specificity remains at 95% (Figs. 2.1, 2.2), and should be considered 
for animal samples. The prevalence of positives in the samples tested was 59% (Table 
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2.1), at a prevalence of 10% (the approximate fraction of positive samples submitted to 
the Animal Health Diagnostic Center based on IHA results), the calculated positive 
predictive value would be 67% with a negative predictive value of 99%. Table 2.2 
documents the range of test performances by species using the kit-recommended 
parameters for distinguishing positive from negative results. In addition, ROC curves are 
provided for all results collectively and by species to evaluate the ELISA’s performance 
when compared to the IHA (Figs. 2.1–2.3). 
 
DISCUSSION 
Antemortem diagnosis of toxoplasmosis presents a challenge due to the nonspecific 
nature or lack of clinical signs. Serologic evaluation provides a useful tool by the ease of 
access to the requisite sample and its high sensitivity to detection of recent and chronic 
infection. However, care must be used in linking an animal’s serologic status to active 
illness due to this same ability to detect historic infection. The cessation of production of 
a commercially available IHA  kit in the United States has led to a critical gap in 
diagnostic options for serologic diagnosis of Toxoplasma infection across a wide range 
of animal species, notably intermediate hosts like goats and sheep in which 
toxoplasmosis can cause significant economic losses. The use of ELISAs for similar 
detection has been limited by the requirement for species-specific anti-IgG conjugate to 
produce valid results. The successful testing of an ELISA that uses conjugates effective 
across many of the animal species of interest provides an additional tool for veterinary 
diagnostic laboratories to use in determining an animal’s serological status. 
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Figure 2.1. Effect of enzyme-linked immunosorbent assay optical density (OD) 
ratio cut-off value on relative sensitivity and specificity. 
 
 
Figure 2.2. Receiver operating characteristic calculation for modified 
immunoglobulin G enzyme-linked immunosorbent assay. 
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Figure 2.3. Receiver operating characteristic calculation by species 
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Table 2.1. 2 × 2 comparison of indirect hemagglutination assay (IHA) to modified 
immunoglobulin G enzyme-linked immunosorbent assay (ELISA) testing. 
 
 
 
 
 
 
 
 
Table 2.2. Kappa value calculation by species. * 
 
*  CI = confidence interval 
 
 
 ELISA+ ELISA– Total 
IHA+ 125 14 139 
IHA– 5 83 88 
Total 130 97 227 
Species 
Serum 
samples 
Kappa value 
(95% CI) 
Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
All tested 
 
227 0.83(0.75–0.90) 0.90(0.83–0.94) 0.95(0.87–0.98) 
Canis 
familiaris 
53 0.77 (0.59–0.94) 0.93 (0.76–0.99) 0.82 (0.60–0.94) 
Capra hircus 
 
39 0.94 (0.81–1.0) 0.97 (0.80–1.0) 1.0 (0.66–1.0) 
Equus 
caballus 
21 0.72 (0.42–1.0) 0.72 (0.39–0.93) 1.0 (0.66–1.0) 
Felis 
domesticus 
26 1.0 (0.57–1.0) 1.0 (0.82–1.0) 1.0 (0.40–1.0) 
Lama pacos 
 
46 0.70 (0.49–0.90) 0.76 (0.54–0.90) 0.95 (0.74–1.0) 
Ovis aries 
 
42 0.91 (0.77–1.0) 0.91 (0.69–0.98) 1.0 (0.80–1.0) 
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Both the previously available IHA and the currently available IgG ELISA allow 
detection of IgG in serum samples, and both provide an antigen substrate to which 
antibody present in the serum will attach. Beyond that, the 2 procedures utilize quite 
different technology to quantify antibody in a given sample. The IHA uses antigen-
coated red blood cells to which antibody attaches for detection, while the ELISA uses U-
shaped wells coated with antigen. The IHA results depend on the subjective 
determination by the operator of the extent of agglutination in an individual reaction to 
establish a maximum positive dilution. The interpretation of ELISA results do not 
depend on subjective evaluation by the operator, as the optical density in the reaction 
well is quantified by a microtiter plate reader. 
In the present experiment, 227 serological samples from diverse animal species 
were evaluated pairwise for the presence of anti-Toxoplasma IgG antibody both by the 
IHA and the IgG ELISA modified with protein A or G techniques. Results indicated very 
good agreement between the 2 tests in determining positive versus negative samples, 
indicated by a kappa value of 0.83. While good agreement is also noted as indicated by 
kappa values for results in each species, evaluation of horse and alpaca samples 
showed lower sensitivities that those of other species (0.72 and 0.76, respectively), 
which should be noted in future use of this method. The modified ELISA described 
herein provides a strong alternative for veterinary diagnostic laboratories in detecting 
exposure to Toxoplasma by serologic evaluation across a range of commonly tested 
animal species. 
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CHAPTER THREE 
CHIMERIC PROTEIN A/G CONJUGATE FOR DETECTION OF ANTI-TOXOPLASMA 
GONDII IMMUNOGLOBULIN G IN MULTIPLE ANIMAL SPECIES 
 
ABSTRACT 
 
Serological testing for toxoplasmosis diagnosis remains the method of choice in 
human medicine due to the accessibility of the requisite sample, the difficulty in 
predicting the parasite’s location in the host for direct detection and the availability of 
established commercial methods.  In veterinary medicine, though the first two conditions 
are unchanged, there is a need for commercially produced test methods that are 
validated for Toxoplasma gondii detection across the range of animal species that can 
serve as intermediate hosts.  The development of a serological method for animals 
would allow the diagnosis of toxoplasmosis in individual animals and a higher 
throughput method for population level toxoplasmosis surveys.  The incorporation of a 
non-species specific chimeric protein A/G conjugate into an anti-Toxoplasma IgG 
enzyme linked immunosorbent assay (ELISA) is described.  Serum from potential 
intermediate hosts was reevaluated using this method and compared to earlier testing 
using an established agglutination procedure.  Very good agreement between the two 
tests was noted (κ = 0.81), establishing the method as a useful option for veterinary 
diagnostic testing. 
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INTRODUCTION 
Toxoplasmosis, caused by Toxoplasma gondii, is a disease that has health and 
economic impacts across a broad spectrum of animal species (Dubey and Jones, 2008; 
Kijlstra et al., 2004; Lindsay and Dubey, 2007).  Diagnosis of toxoplasmosis is 
complicated both by the non-specific nature of clinical signs and the complexity of the 
pathogen’s life cycle making direct detection unfeasible in most situations (Dubey, 1995; 
Dubey, 2004; Dubey et al., 1977; Ferguson and Dubremetz, 2007; Speer and Dubey).  
There are a range of serological options that have been developed to detect exposure 
to Toxoplasma in humans, some of which have utility in veterinary diagnostics (Montoya 
and Liesenfeld, 2004; Remington et al., 2004).  Various permutations of agglutination 
testing can be applied successfully to testing a wide range of animal species, as they 
have no species specific conjugate requirement (Chordi et al., 1964; Desmonts and 
Remington, 1980; Jacobs and Lunde, 1957).  However, there are no commercially 
produced agglutination tests currently available in the United States, whereas many 
other serological tests are either available or being developed for human testing 
(Remington et al., 2004).  Unfortunately, many of these tests require protein conjugate 
for the detection of anti-Toxoplasma antibody in the serum of interest.  Most of the 
protein conjugates available are only effective in binding to antibody from specific 
animal species.  The description of the use of protein conjugates that bind to the IgG of 
many different animal species is a promising new platform for serological test 
development (Schaefer et al., 2011; Werre et al., 2002; Zhang et al., 2010) . 
The use of non-species-specific protein conjugates A and G allows the testing of 
sera from most of the veterinary species of interest on an ELISA platform.  However, 
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this requires two parallel tests to be run with two sets of control, one for samples to be 
tested with protein A conjugate and one for those to be tested with protein G.  The 
development of chimeric protein A/G conjugate from Staphylococcal protein A and 
Streptococcal protein G has been described (Eliasson et al., 1988).  This chimeric 
protein A/G conjugate allows the testing of all species formerly tested by the two 
proteins individually with a single conjugate, thereby simplifying the procedure to be 
more attractive as a potential substitute for currently utilized agglutination techniques 
(Bhide et al., 2004; Zhang et al., 2010).   A single test allows higher throughput and is 
better suited to commercial development and automation.   In this study, the results of a 
commercially produced indirect hemagglutination assay were compared with those of a 
commercially available IgG ELISA, modified to detect IgG antibody in multiple animal 
species by the substitution of protein A/G horseradish peroxidase conjugate for the kit 
provided anti-human conjugate. 
 
MATERIALS AND METHODS 
Blood samples were collected in clot tubes from animals by referring 
veterinarians. The extracted serum samples were submitted to the Animal Health 
Diagnostic Center at Cornell University (Ithaca, New York) from 2002 to 2008 for 
detection of Toxoplasma exposure by indirect hemagglutination. After storage at 5ºC, 
positive samples with a sufficient amount of serum remaining and a sampling of 
negative samples were reassessed using the modified IgG ELISA technique in 2011. 
The sera tested included samples from 14 alpacas, 17 sheep, 17 goats, 15 horses, and 
56 dogs. 
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Seroreactivity to Toxoplasma antigens was initially evaluated using an indirect 
hemagglutination assay (IHA).a  The commercial preparation of the IHA had perfect 
qualitative agreement with the Center for Disease Control and Prevention (CDC) 
Toxoplasma indirect immunofluorescence test in their evaluation of human serum 
samples (Wilson et al., 1987).  Serum containing anti-Toxoplasma antibody causes 
agglutination of the sheep red blood cells coated with antigen as part of the test 
procedure (Chordi et al., 1964; Jacobs and Lunde, 1957).  Nonspecific agglutination is 
detected by assaying coated and non-coated red blood cells in separate wells. 
Interpretation is based on observation of presence or absence of a red blood cell mat 
covering the bottom of the test well on completion of incubation. The test is equally 
effective for human and animal diagnostic work since no species-specific conjugate is 
required for antibody detection (Wilson and McAuley, 1991).  This procedure was used 
as a reference test to evaluate the performance of the modified IgG ELISA, with details 
described in an earlier study (Schaefer et al., 2011). 
A commercial IgG ELISAb was modified by use of protein A/G horseradish 
peroxidase conjugatec to replace the conjugated goat anti-human IgG included in the kit.  
Samples, controls, and a calibrator were evaluated after dilution 1:21 with kit-supplied 
diluent (containing Tween-20, bovine serum albumin, and phosphate buffered saline). 
These were added to kit wells that had been sensitized by passive absorption with 
Toxoplasma antigen. Any antigen-specific antibody contained in the sample binds to the 
immobilized antigen. Protein A/G conjugate was added to each well to attach to any 
immobilized IgG antibody. Following washing, microwells were incubated with 
tetramethylbenzidine, a peroxidase substrate solution that changes color when 
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hydrolyzed by the presence of peroxidase. Color intensity of the sample indicated 
antibody concentration in the microwell. This was evaluated using a microplate reader 
with light at a wavelength of 450 nm. Comparison to kit-provided calibrators guided the 
identification of positive versus negative serum, with a ratio of sample color intensity to 
kit calibrator color intensity of greater than or equal to 1.1 indicating a positive reaction 
for anti–Toxoplasma IgG antibody as described by the kit insert. A ratio between 0.9 
and 1.1 (non-inclusive) was considered an indeterminate result, and less than or equal 
to 0.9 was considered a negative result. 
Protein A/G chimeric horseradish peroxidase conjugate was used in the IgG 
ELISA assays instead of the kit conjugate to allow testing of multiple animal species. 
This protein is produced by gene fusion of the Fc-binding domains of protein A and 
protein G, bacterial cell wall proteins with affinity for IgG in a range of species.   It 
contains four Fc-binding domains from protein A and two from protein G, providing 
binding for all antibody species and subclasses recognized by either protein A or protein 
G (Eliasson et al., 1988).   Protein A conjugate is reported to provide strong binding to 
IgG antibody of mice, rabbits, cats, dogs, and pigs, whereas protein G conjugate is 
reported to provide strong binding to IgG antibody of mice, guinea pigs, rabbits, cows, 
sheep, goats, alpacas, horses, and pigs (Bjorck and Kronvall, 1984; Schaefer et al., 
2011; Surolia et al., 1982).  Protein was received as lyophilized powder and was diluted 
1:40,000 with phosphate buffered saline (pH 7.2) prior to use. The dilution was 
determined by testing against kit controls to satisfy quality control parameters.  
The significance of association between the results of the IHA and the ELISA 
was evaluated using the McNemar’s Chi-square test (McNemar, 1947).  The degree of 
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agreement between the results from the two tests was quantified using Kappa statistics. 
The accuracy of the ELISA test in detecting exposure to Toxoplasma was evaluated in 
comparison to the IHA and measured using the relative sensitivity and specificity. The 
expected performance of the ELISA at different cut-off points was examined using the 
receiver operating characteristic (ROC) curve (Greiner et al., 2000). 
 
RESULTS 
Serum samples were evaluated from multiple animal species using both the IHA 
and the IgG ELISA modified as described.  The sera tested included samples from 
some of the more commonly tested intermediate hosts for the parasite.  There was no 
significant difference detected between positive versus negative results when 
comparing IHA and ELISA results with McNemar’s Chi-square (p=1.0), with a kappa 
value of agreement of 0.81 (95% confidence interval [CI]: 0.71-0.92 calculated using 
GraphPadd), as noted in Table 3.1.  This reaffirms the finding of our earlier study using 
protein A and G conjugates individually of very good agreement between the 
agglutination and ELISA testing.  The breakdown of these results by animal species is 
provided in Table 3.2, with all species, except horses, demonstrating very good to 
perfect agreement between the two test methods.  The precision of the assay was 
determined to be very good, with a Kappa value of 0.90 (95% CI: 0.81-1.00) found when 
repeated assays were performed using the same serum samples (Table 3.3).  The 
relative sensitivity of this ELISA using chimeric protein A/G conjugate was found to be 
92% (95% CI: 82-97%) and relative specificity 89% (95% CI: 77-96% calculated using 
VassarStatse) when the IHA results were utilized as a gold standard and positive versus 
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negative ELISA results were determined using the manufacturer’s guidelinesb, including 
0.9 to 1.1 as the equivocal range for optical density ratios.  The variation of relative 
sensitivity and specificity at different optical density ratios is shown in Figure 3.1.  The 
associated Receiver Operating Characteristic (ROC) curve is depicted in Figure 3.2. 
 
DISCUSSION 
 The use of chimeric protein A/G conjugate has previously been demonstrated to 
be an effective means of serological testing in domestic animals (Bhide et al., 2004).  
An earlier study explored its use for diagnostic testing in goats, dogs, cats, and pigs 
using an ELISA method developed in the researchers’ laboratory (Zhang et al., 2010).   
In this study, a commercially produced IgG ELISA kit for the diagnosis of Toxoplasma in 
humans was modified to broaden the application of the test to domestic animals that 
can act as intermediate hosts of the parasite, having the benefit of being easily available 
to veterinary diagnosticians.  Across the species tested, the modified kit produced a 
relative sensitivity of 92% and specificity of 89% using kit standards for determination of 
positive, equivocal and negative tests when the IHA was used as a gold standard.  At 
the current time, there are no commercially available tests in the United States for the 
diagnosis of toxoplasmosis that can be used across the broad spectrum of animal 
species that can be affected.  This project demonstrates that a human ELISA kit can be 
modified with the replacement of a non-species specific protein conjugate for the 
supplied anti-human IgG protein conjugate, and produce very good results for some of 
the more commonly tested animal species.  Non-species specific protein conjugates,  
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Figure 3.1. Variation in sensitivity and specificity relative to enzyme-linked 
immunosorbent assay optical density (OD) ratios. 
 
 
Figure 3.2. Receiver operating characteristic calculation for modified immunoglobulin G 
enzyme-linked immunosorbent assay. 
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Table 3.1. Comparison of indirect hemagglutination to modified IgG ELISA. 
 
 ELISA + ELISA - Total 
IHA + 58 5 63 
IHA - 6 50 56 
Total 64 55 119 
 
 
Table 3.2. Results of modified IgG ELISA testing by species. 
 
Species Samples 
Tested 
True 
Positive 
False 
Positive 
False 
Negative 
True 
Negative 
Kappa 
Value 
Alpacas 14 8 1 0 5 0.85 
Sheep 17 10 0 0 7 1.0 
Goats 17 11 0 0 6 1.0 
Horses 15 2 1 4 8 0.24 
Dogs 56 27 4 1 24 0.82 
 
Table 3.3. Comparison of repeated assays using modified IgG ELISA 
 First Run + First Run - Total 
Second Run + 47 2 49 
Second Run - 2 33 35 
Total 49 35 84 
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like protein A/G, have great utility in developing new veterinary diagnostic testing 
methods for zoonotic diseases in which there are only medical diagnostic methods 
available. 
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CHAPTER FOUR 
TOXOPLASMA GONDII SEROPREVALENCE IN NEW YORK STATE WHITE-TAILED 
DEER (ODOCOILEUS VIRGINIANUS) 
ABSTRACT 
Serum samples collected from 299 white-tailed deer (Odocoileus virginianus) that 
were killed in New York State by hunters in November 2010 were assayed for the 
presence of anti-Toxoplasma gondii IgG antibodies.  White-tailed deer are a useful 
sentinel for risk of human and domestic animal exposure to Toxoplasma oocysts and a 
potential risk for infection to humans and other animals by ingestion of the meat.  This 
herbivorous species shares grazing space with domestic animals raised for meat, and is 
likely to be exposed by horizontal transmission through oocyst consumption, similar to 
other grazing species of economic concern.  Overall, 42.2% of serum samples in the 
present study were seropositive on an enzyme-linked immunosorbent assay (ELISA), 
indicating a true prevalence of 38.5%, with a significantly higher proportion of adult than 
immature deer testing seropositive.  No significant difference in seropositivity was noted 
between male and female deer, nor was there significant correlation between local 
human population density and deer seropositivity.  These results provide insight on the 
risk of environmental Toxoplasma exposure in New York State and support horizontal 
transmission through oocyst consumption as the most common mechanism of white-
tailed deer infection. 
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INTRODUCTION 
Toxoplasmosis is caused by infection with Toxoplasma gondii, and is considered 
to be one of the most common protozoal infections in the world and the third leading 
cause of human death from foodborne disease in the United States (Lindsay et al., 
2003; Mead et al., 1999).  Human infection is common, though it varies significantly 
across different geographic areas (Dubey, 2010).  Exposure can be due to vertical or 
horizontal transmission, with the latter considered the most common means, by 
consumption of tissue from an infected intermediate host or by ingestion of oocysts 
produced by the definitive hosts, domestic and wild felids (Dubey, 2008).  Significant 
morbidity from Toxoplasma is uncommon in most infections, with the exception of fetal 
infection due to exposure of the mother and infection in immunocompromised 
individuals.  Similarly, animal infection is quite common across a broad range of both 
domestic and wild warm blooded species, with little pathology typically noted.  A 
particular concern is the infection of food animals, both due to potential reproductive 
effects in the animals and the risk of tissue cysts to consumers in the meat or other 
tissues (Dubey and Jones, 2008).  Toxoplasmosis is of known economic concern 
among goat and sheep producers and an emerging concern among camelid producers 
(More et al., 2008).   
It can be assumed, barring supplementation with or inadvertent ingestion of 
animal products, that grazing animals are primarily exposed by either vertical 
transmission from infected mothers or by consuming oocysts on contaminated 
feedstuffs.  The population density and gregarious nature of deer make them a suitable 
proxy to characterize risk factors for infection in common with other grazing animals 
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(Kirchgessner et al., 2012), and the use of their meat for human and animal 
consumption makes their infection with Toxoplasma a point of interest for public and 
domestic animal health.  The importance of deer as a potential source of infection has 
been suggested by research noting a higher degree of Toxoplasma exposure among 
consumers of venison than among the general population (Ross et al., 2001; Sacks et 
al., 1983). 
White-tailed deer are the subject of intensive control efforts related to their 
propensity to cause physical damage to property and as a species contributing to the 
spread and maintenance of zoonotic and economically significant diseases (DeNicola et 
al., 2000; Forrester, 1992).  Control efforts aimed at reducing Ixodes scapularis (black-
legged or deer tick) populations in the northeastern US by targeting deer have met with 
some success, but also have emphasized the difficulties of control of such a large and 
mobile wildlife population.  Additionally, deer live in intimate association with human and 
domestic animal populations, making some lethal control efforts difficult and often 
unpalatable to the local residents (Porter et al., 1991).  These factors make deer a 
useful sentinel species for the study of the prevalence of pathogenic agents that pose a 
risk to humans and other animals, and the ready availability of tissue samples during 
hunting season provides a unique opportunity to test significant numbers.  Previous 
research has noted Toxoplasma seroprevalences in white-tailed deer that ranged from 
30% to 64.2% in US state surveys (Dubey, 2010; Dubey et al., 2009; Vanek et al., 
1996).  A seroprevalence of 60% was detected among deer killed in Pennsylvania, the 
closest previous study to the present population (Humphreys et al., 1995).  There are no 
reports of clinical toxoplasmosis in white-tailed deer, suggesting that infection is not be 
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a predisposing factor in being harvested by hunters, though more research on this point 
is of  interest given behavior anomalies observed in other intermediate hosts (Afonso et 
al., 2012; Gatkowska et al., 2012).   
The examination of Toxoplasma seroprevalence in the population of hunter-killed 
New York State deer can provide insight into the dynamics of infection among wildlife 
and domestic animal populations.  Inferences can be made regarding the level of 
exposure based on sex, age, and the human population density of the town in which the 
deer were killed.  Differences in male vs. female levels of infection may suggest sex-
based risk factors promoting exposure.  Age based differences in infection level can 
help to determine how the population of deer have been exposed; e.g. a constant level 
of infection across age groups would suggest a larger role for vertical exposure, 
whereas an increasing level of infection with age would suggest horizontal transmission 
through environmental exposure as a more important route.  Finally, the interaction 
between the local human population density and infection levels in the associated deer 
may provide insight into the importance of the presence of domestic cats in serving as a 
route of exposure.  Human population will be used as a proxy for cat population, as 
accurate estimates of the latter are lacking, whereas census based data for the former 
is available.  However, discrepant results between level of cat population density and 
seroprevalence in deer may be due to management factors, i.e., rural owners may be 
more likely to allow cats to roam freely outside, leading to more potential oocyst 
contamination than would be seen with urban, primarily indoor cats.  Additionally, a 
significant level of Toxoplasma infection was noted in Pennsylvania bobcats (Lynx rufus 
rufus) which are able to shed oocysts into the environment (Mucker et al., 2006).  This 
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contribution is expected to be minimal compared to that of domestic cats, as the bobcat 
population in New York State is estimated at only 5,000 (NYS DEC, 2012).   
This study describes analysis of 299 white-tailed deer serum samples from 
animals killed during November 2010 across New York State for antibodies to 
Toxoplasma as an indication of their exposure history.  Whole blood was collected from 
the thoracic cavity of freshly killed deer at deer processing establishments across the 
state, processed to serum, frozen and stored at the State University of New York’s 
College of Environmental Science and Forestry pending further analysis (Kirschgessner 
et al., 2012).  Serum samples were assayed by an enzyme-linked immunosorbent 
assay effective for the detection of IgG in a broad range of animal species (Schaefer et 
al., 2012).  Demographic information that had been collected for the deer was 
contrasted between seropositive and seronegative deer to identify significant risk 
factors.  Results suggest broad characterizations that can distinguish seropositive from 
seronegative deer and lend themselves to risk analysis for meat producers and 
consumers of venison. 
 
MATERIALS AND METHODS 
Sample Processing 
Blood samples were collected from the thoracic, nasal or oral cavities of hunter-
harvested white-tailed deer at private deer processing facilities and New York State 
Department of Environmental Conservation (NYSDEC) deer check stations across New 
York State.  Collections were performed November 20-21, 2010, the first weekend of 
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the 2010-2011 regular firearm season in the majority of the state.  Blood was 
transferred to 10-mL glass serum tubes and stored at 4ºC prior to centrifugation at 1300 
g for 10 minutes.  Supernatant (serum) was collected and frozen at -80ºC pending 
further analysis (Kirchgessner et al., 2012).  A total of 299 serum samples,100 from 
females and 199 from males, were evaluated as described below. 
ELISA 
Serum samples were tested for the presence of anti-Toxoplasma IgG using the 
technique described in Schaefer et al., 2012.  The Wampole Laboratories’ Toxoplasma 
gondii IgG ELISA II kit provided antigen coated wells were filled with the serum of 
interest, allowed to incubate and washed with kit supplied wash buffer.  Protein A/G 
conjugate diluted to 1:40,000 with PBS was used for detection of antigen-antibody 
bonds instead of the kit-supplied anti-human IgG conjugate.  Following incubation and a 
second wash step, tetramethylbenzidine (TMB) was added as an indicator of the 
presence of conjugate and color intensity was measured on a microplate reader at a 
wavelength of 450 µm.  Optical density ratios were calculated using kit supplied 
standards and used to determine serological status.  
Data Analysis 
Samples were categorized as “positive” vs. “negative” based on the results of the 
ELISA assay.  Results in the equivocal range were noted for 31 of the samples, which 
were excluded from further analysis.  Positive samples were considered cases and 
negative samples were considered controls for purposes of risk factor interpretation.  A 
logistic regression was performed using JMP9 software with variables of age (less than 
58 
 
one year old vs. greater than one year old), sex and human population density in the 
town in which each deer was killed with output of serological status.  Significant factors 
contributing to serological status were identified and further analyzed by determining 
odds ratio with 95% confidence intervals.  ArcGIS10 was used to produce a New York 
State map indicating towns from which seropositive deer were identified and those in 
which none of the deer sampled for this investigation were positive for Toxoplasma 
antibody. 
 
RESULTS 
Samples that produced optical density ratio values in the equivocal range were 
excluded from analysis, leaving 113 samples that were determined to be positive and 
155 that were negative for Toxoplasma exposure, giving an apparent prevalence of 
42%.  The ELISA test had previously been demonstrated to have a sensitivity and 
specificity of 92% and 89%, respectively, using agglutination testing as a gold standard 
(Schaefer et al., 2012).  Using calculations for true prevalence based on test 
performance, our testing indicates a prevalence of 38.5% (95% confidence interval of 
31.2 - 45.8%) for this population of deer (Rogan and Gladen, 1978). 
Logistic regression analysis was conducted using JMP9, with age, sex and town 
population density as predictors and serological status as the outcome.  Age of > 1 year 
was determined to be a significant factor in increasing risk of seropositivity (p=0.0013), 
whereas the effects of sex and local human population density were found to be 
insignificant (p=0.4831 and 0.1285, respectively).  Seropositivity values were 20.6% for 
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the younger group vs. 46.8% for the older group.  The odds ratio for seropositive deer 
that were greater than a year old to those that were less than a year old was calculated 
to be 3.39 (95% confidence interval of 1.42-8.12).  When distinguished by sex, 38.9% of 
females were seropositive on the ELISA, vs. 43.8% of the males.  Human population 
density was analyzed as a continuous variable, with no significant trend in relation to 
seropositivity detected. 
Locations from which deer were collected were noted below on a map of upstate 
New York created using ARCGIS10, with diamonds indicating the towns from which 
deer were collected.  Black diamonds indicate those towns from which at least one deer 
was found to be seropositive for Toxoplasma, whereas white diamonds indicate those in 
which none of the deer killed were found to be seropositive.  Shading increase with 
increasing human population density by zip code as noted (Figure 4.1). 
 
DISCUSSION 
The widespread exposure of deer to Toxoplasma in New York State is indicated 
by a seroprevalence of 38.5% in this group of deer killed by hunters in November 2010.  
This level is consistent with prevalences described from other states, but lower than that 
60% noted in a Pennsylvania study from 1995 (Dubey, 2010; Humphreys et al., 1995).  
Older deer were noted to have a significantly higher risk of being seropositive, whereas 
no significant difference was noted between male and female levels of exposure.  The 
local human population density did not appear to be a risk factor for infection.  This is 
consistent with infection of the deer by horizontal transmission, with the risk of having 
60 
 
 
Figure 4.1. Localities from which seropositive deer were collected (♦) and from 
which only seronegative deer were collected (◊), with background shading 
indicating human population density. Produced with ARCGIS10. 
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ingested oocysts increasing with increasing age.  A map of upstate New York indicating 
collection sites and the presence or absence of seropositive samples was created.  It 
should be noted that these were convenience samples with sites and the numbers of 
samples from each site not being standardized.  No conclusions regarding these 
specific locations and the presence or absence of Toxoplasma oocysts in the 
environment should be derived from these results beyond noting the widespread nature 
of seropositive sites.   
The relation to human population analysis was performed based on the town in 
which the deer was killed.  It has been found that average deer ranges are 2.8 – 4.9 
km2 in yearling male white-tailed deer, with female deer known to have a more limited 
range (McCoy et al., 2005).  A New York study conducted in the Adirondacks noted an 
average range for white-tailed deer of 2.25 km2 in the summer and 1.35 km2 in the 
winter (Tierson et al., 1985).  The towns from which these deer were collected are 
generally greater than 100 km2 in area, making it likely that most Toxoplasma exposures 
would have occurred in the town of collection, but overlap with neighboring towns is 
certain to be seen.  When human population density was analyzed as a continuous 
variable, no significant prediction of seropositivity was noted.  This group of samples 
was highly skewed for analysis since most of the deer were collected from rural towns 
with a median human population density of 25 residents/km2. In one measure, the 
United States Census considers urban areas as those with at least 386 residents/km2.  
Future sample collections including more populated Hudson River Valley suburban 
townships that allow hunting will allow comparison of Toxoplasma prevalence in deer 
from towns with a wider range of population densities.   
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The potential relationship between human population density and Toxoplasma 
seropositivity in deer may be due to a greater domestic feline population density and 
therefore greater environmental oocyst contamination. Since this is the expected route 
of exposure for deer it needs to be investigated further.  Deer feeding behavior in areas 
of greater human population density may be expected to include grazing closer to 
human habitations, areas in which owned cats are more likely to defecate.  This 
scenario is based on domestic cats being the singular source of Toxoplasma oocysts. 
Bobcats, the only other expected feline source of oocysts in the region, comprise a 
fraction of the domestic cat population, as noted above. Conversely, rural areas might 
be expected to harbor more cats that spend time outdoors and participate in rodent 
consumption, thereby being more likely to be infected with Toxoplasma.  Interestingly, a 
study in Ohio noted greater exposure in deer from areas of lower human population 
density (Crist et al., 1999), potentially supporting the latter scenario.  Further 
investigation including deer from more diverse areas in the state will help to clarify this 
question, and thereby provide a more accurate estimate of factors that contribute to 
Toxoplasma infection in deer and their role in human exposure. 
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CHAPTER FIVE 
PCR DEVELOPMENT AND DETECTION OF TOXOPLASMA GONDII DNA IN 
INFECTED DOGS (CANIS FAMILIARIS) AND SHEEP (OVIS ARIES) 
 
ABSTRACT 
The antemortem diagnosis of Toxoplasma infection in animals is typically 
accomplished by detection of IgG or IgM antibody in serological samples.  While 
demonstrating a history of exposure to Toxoplasma gondii, serological testing cannot 
definitively determine the stage or severity of the infection with precision.  The ability to 
speciate Toxoplasma-like oocysts and tissue cysts will assist both diagnostic and 
etiological investigation.  The advent of molecular methods allows both more specific 
description of protozoal infections, as well as the ability to localize the infection in 
distinct anatomical locations.  Following determination of an optimal primer set for 
detection, a real time quantititative polymerase chain reaction was developed and 
tested against both positive control samples derived from Toxoplasma tachyzoite 
culture and canine and ovine serum samples that were determined to be positive for 
antibody by agglutination testing.  The limit of detection was determined to be four 
copies using cloned DNA of known concentration.  Neither Toxoplasma positive nor 
negative serum from goats and dogs produced positive results on the PCR assay, 
suggesting serum is an inappropriate tissue for diagnostic testing using PCR. 
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INTRODUCTION 
Serological detection has been the primary method for the diagnosis of Toxoplasma 
infection in both humans and animals.  Direct detection of the parasite is complicated in 
the definitive feline host by the transient appearance of oocysts in feces and in 
intermediate hosts by the difficulty in predicting the precise location of tissue cysts 
(Dabritz and Conrad, 2010; Dabritz et al., 2007; Dubey, 1995; Dubey, 2001; Dubey et 
al., 1977).  While serology provides evidence of past exposure, a single sample does 
not allow the characterization of an acute versus a chronic infection, nor the severity of 
the infection.  The direct detection of DNA by polymerase chain reaction seems to be a 
promising method in that a positive result establishes the presence of the organism in 
the tested tissue.  However, the nature of the organism’s complex life cycle poses a 
challenge in translating a successful PCR assay into a useful clinical test.   
  
Advent of PCR for Toxoplasma 
There are two commonly used targets for the detection of genomic DNA by either 
traditional or real time PCR, the B1 gene and AF146527 (529 base pair repeat 
element).  The B1 gene was initially detected as a PCR target with 35 repeats in the 
Toxoplasma genome by Burg et al. (1989), who determined a limit of detection of one 
organism in cell lysate and 10 organisms in a human leukocyte preparation by 
traditional PCR, with no evidence of detection of closely related pathogens.  The B1 
gene has become a standard target for PCR detection of Toxoplasma in clinical 
samples and, significantly for veterinary diagnostics, does not occur in Neospora 
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caninum (Chabbert et al., 2004; Schatzberg et al., 2003).  More recently, a 529 base 
pair target (AF146527) that is repeated 200-300 fold in the Toxoplasma genome has 
been described and utilized as a target for PCR detection (Homan et al., 2000).  No 
statistically significant difference in sensitivity or specificity between the B1 gene and 
AF146527 targets were noted in some investigations (Filisetti et al., 2003; Remington et 
al., 2004), whereas other studies noted that assays for 529 were more sensitive for a 
variety of fluid and tissue samples (Calderaro et al., 2006; Cassaing et al., 2006; Dubey, 
2010; Homan et al., 2000; Reischl et al., 2003).  Investigation of sequence variation 
across Toxoplasma strains from human infections noted that the AF146527 element is 
absent in 4.8% of cases, which may lead to false negative determinations even if the 
organism is present in the tissue being evaluated (Wahab et al., 2010). 
 
Current utility of PCR 
Both methods are used for detection of Toxoplasma in diverse tissues in human 
and veterinary diagnostic investigation.  Samples commonly evaluated from suspected 
human cases include:  amniotic fluid, placenta, brain, blood, cerebrospinal fluid, urine, 
vitreous, aqueous, bronchoalveolar lavage, pleural and peritoneal fluids (Remington et 
al., 2004).  Veterinary diagnostic laboratories offer evaluation of blood, feces, CSF, 
brain and other tissues, with fecal examination used to distinguish Toxoplasma oocysts 
from morphologically similar Hammondia hammondi in feline feces (Schares et al., 
2008).  Knowledge of the parasite’s life cycle is critical to increase the utility of PCR 
testing, e.g. blood stages are transient and expected early in infection, and detection of 
the parasite in tissue relies on the presence of a tissue cyst in the aliquot being tested.  
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Even with a good sampling strategy, molecular detection must be considered a method 
of unproven sensitivity but good specificity, where the predictive value of a positive 
result is much higher than that of a negative result (Remington et al., 2004).  This 
makes molecular detection a reasonable adjunct to serological investigation, in which 
the opposite is true regarding positive and negative predictive values.  The 
establishment of a reliable real time PCR protocol for detection of Toxoplasma DNA will 
allow definitive diagnosis of the presence and stage of infection when serological testing 
produces equivocal results.  This study describes a comparison of protocols for 
Toxoplasma detection by traditional PCR and the development of a real time PCR 
assay to test on serum samples from seropositive and seronegative dogs and sheep. 
 
MATERIALS AND METHODS 
 
Cell Culture 
Cultured tachyzoites were acquired from the laboratory of Dr. Eric Denkers 
(Cornell University, Ithaca, NY).  Tachyzoites of Type I Toxoplasma strain RH had been 
maintained by bi-weekly passage on human foreskin fibroblast monolayers (American 
Type Tissue Collection) in Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
with 1% Bovine Growth Serum, 100 U/ml penicillin and 0.1 mg/ml streptomycin. Two 
100 µl aliquots of culture media containing approx. 5,000,000 tachyzoites each were 
subjected to DNA extraction.  
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Sample Collection and Processing 
Blood samples were collected in clot tubes from animals by referring 
veterinarians to allow serum separation and collection. They were submitted to the 
Animal Health Diagnostic Center at Cornell University (Ithaca, New York) from 2002 to 
2007 for the detection of Toxoplasma exposure by indirect hemagglutination.  Nine 
serum samples were used for this study, including four canine samples (three 
seropositive and one seronegative) and five ovine samples (four seropositive and one 
seronegative). 
 
DNA Extraction 
 DNA was extracted from both the cultured tachyzoites and 200 µl aliquots of 
sera using the QIAamp DNA Mini Kit’s protocol.  The ratio of 260 nm to 280 nm and 
concentration of DNA was tested using a nanodrop spectrophotometer (Table 5.1).   
 
Primer Development 
Two primer sets were chosen based on previously published work using the B1 
gene and 529 targets, the former amplifying a 94-bp internal fragment and the latter a 
98-bp internal fragment (Edvinsson et al., 2006).  The 529-bp repeat element exists in 
the genome in 200-300 copies, whereas the B1 gene occurs in 35 copies.  This leads to 
the prediction that an assay targeting the 529-bp repeat element would be more 
sensitive than one targeting the B1 gene.  Experimental results attempting to verify this 
prediction have been mixed, with some detecting greater sensitivity using the 529 assay 
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and others detecting no significant difference (Cassaing et al., 2006; Filisetti et al., 
2003).  The B1 gene and 529-bp repeat element published primers were used and 
results were compared for positive controls in the presence and absence of serum and 
extracted sera on traditional PCR assays.  Additionally, two new primers targeting the 
529-bp repeat element were developed and similarly evaluated.  The primers that 
produced significant bands at the predicted size without the presence of non-target 
bands (in this case the B1 gene primers) were then used in a Sybr-green real-time PCR 
assay to detect the limit of their sensitivity using a cloned amplicon. 
Novel primer sets for the detection of Toxoplasma DNA by targeting the 529-bp 
repeat region were developed using the published sequence designated AF146527 on 
the National Center for Biotechnology Information’s (NCBI’s) website.  Primers were 
chosen based on the design recommendations described in Bio Rad Laboratories 
website (www3.bio-rad.com):  guanine-cytosine (GC) content of 50-60%, melting 
temperature between 50-65º C, lack of secondary structure, no G or C repeats greater 
than 3 bases and Gs and Cs on the end of the primers.  One forward primer and two 
reverse primers were identified based on these criteria, with the aid of Dr. Michael 
Zuker’s DNA mfold server to analyze secondary structures 
(www.bioinfo.rpi.edu/applications/mfold/).  The predicted amplicon sizes were 135 bp 
and 116 bp (Table 2). 
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Table 5.1. DNA quantitation in extracted Toxoplasma culture and serum samples. 
Sample 260/280 Concentration (ng/µl) 
Tachyzoites #1 2.35 31.6 
Tachyzoites #2 2.26 31.1 
Sample #1 (+ canine) 1.15 51.5 
Sample #2 (+ canine) 1.20 9.7 
Sample #3 (+ canine) 1.25 19.6 
Sample #4 (- canine) 1.66 6.7 
Sample #5 (+ ovine) 1.33 9.8 
Sample #6 (+ ovine) 1.08 7.0 
Sample #7 (- ovine) 1.34 6.5 
Sample #8 (+ ovine) 1.23 45.6 
Sample #9 (+ ovine) 1.00 16.2 
Distilled water 1.64 2.2 
 
Table 5.2. Primers used to amplify indicated target. 
TARGET Size(bp) Primer 1 Primer 2 
B1 gene 98  CGT CCG TCG TAA TAT 
CAG 
GAC TTC ATG GGA CGA TAT 
G 
529 
element 
94  CAC AGA AGG GAC AGA 
AGT 
TCG CCT TCA TCT ACA GTC 
529(js1) 135  CTT GGA GCC ACA GAA 
GGG 
CTT CCC AAC CAC GCC ACC 
529(js2) 116  CTT GGA GCC ACA GAA 
GGG 
CCT CAT CCT CAC CCT CGC 
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Traditional PCR 
The four primer sets were tested using positive control DNA extracted from 
cultured tachyzoites.  All four assays produced positive results in duplicate at the 
predicted size as indicated by Figure 5.1.  Published primers 529 were subjectively 
noted to have produced less significant bands, while primers 529js2 produced non-
target banding, which can complicate quantitative interpretation if utilized on a real-time 
platform.  Therefore primers for B1 gene and 529js1 were used for evaluation of clinical 
samples, with no amplification of seropositive nor seronegative dog and goat samples 
detected (Figure 5.2).  Non-target banding was noted in 529js1, leading to the choice of 
B1 gene primers for further development. 
 
Cloning 
B1 gene primers were used for real-time PCR analysis of positive controls and 
samples following traditional PCR analysis.  The Escherichia coli (E. coli) plasmid 
cloning vector pUC19 was prepared for cloning using the Qiagen Plasmid Purification 
Kit (Midi).  After establishing a significant concentration of DNA present in the resulting 
solution (555 ng/µl), plasmid DNA was cut and linearized by digestion with restriction 
enzymes EcoR1 and Pst1.  Agarose gel electrophoresis allowed separation of the larger 
(2646 bp) from the smaller (40 bp) fragment and the latter was collected by physical 
excision and the use of a gel extraction kit (QIA Quick PCR Purification).  B1 gene 
primers were modified by the addition of EcoR1 sequence to the forward and Pst1 
sequence to the reverse, and used to produce an abundance of amplicon by the same 
technique.  The plasmid and B1 gene amplicon were ligated by use of the Fast-Link  
74 
 
          
100 bp Primer 529          B1  529js1     529js2 
  Ladder 
 
Figure 5.1. Results of traditional PCR testing of 31.1 ng positive control using (from left 
to right) primers for 529 repeat element, B1 gene, and newly developed primers 529js1 
and 529js2. 
 
 
 
 
 
 
Figure 5.2. B1 gene and 529js1 evaluation of extracted canine and caprine sera:  (left 
to right) 100 bp ladder, B1 gene assay (3 ng positive control, negative control, + dog, - 
dog, - goat, + goat, extracted H20) 529 repeat sequence assay (same order of 
samples). 
 
 
  No serum added   Serum added 
 
       L      104  103   102   10       1    0.1    MT       104   103    102   10      1    0.1 
 
 
 
Figure 5.3. Lack of inhibition of negative serum (canine) – left dilution series of positive 
control without serum, right with serum (approximate number of organisms noted) 
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DNA Ligation kit (Epicentre Biotechnologies) then added to lysogeny broth (LB) 
containing DH5α E. coli.  Following plating on LB, appropriate colonies were removed 
and transferred to ampicillin plates, then broth to select for plasmid containing bacteria  
and to allow further growth.  QIA preparation mini kits were used to extract DNA from 
the recombinant bacteria and linearization using restriction enzyme ScaI was 
performed. The QIA Quick PCR Purification Kit was then used to isolate the linearized 
plasmid including the insert DNA in two aliquots.  The resultant DNA concentration and 
260/280 ratios were 68.1 and 79.0 ng/µl and 1.91 and 1.89, respectively.  This 
represents a relatively pure sample of target DNA when compared to the positive 
control extracted from cultured cells, and allows a more accurate evaluation of test 
sensitivity. 
 
Real Time PCR 
The molecular weight of each plasmid containing the insert was estimated at 
approximately .003 femtograms.  This information was used to create a dilution series 
from 2.27 x 109 to 0.0227 particles/µl.  Initially a traditional PCR with B1 gene primers 
was used, with 5 µl of template per reaction, to give a dilution series from 142,000 
particles to 0.142 particles to be evaluated.  Results seemed to indicate a very good 
sensitivity, however a light band at the same target size was present in the negative 
control well on multiple observations, so no definitive sensitivity was established by this 
technique.  The plasmid with insert DNA was reevaluated using real time PCR using a 
dilution series of 40,700 to 0.407 particles per reaction on a Sybrgreen platform. 
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RESULTS 
 
Traditional PCR testing of a positive control with all four primer sets (B1 gene, 
529 repeat element, and the two newly developed 529 primers) all revealed strong 
positives at the appropriate size (Figure 5.1).  However, all three primers based on the 
529 repeat element also produced multiple light non-target bands, and were therefore 
less suitable for Sybr-green real time PCR development due to potential issues with 
specificity.  Testing of extracted sera from seropositive and seronegative dogs and 
goats did not reveal the presence of Toxoplasma DNA at the predicted size by either B1 
gene or 529 repeat element assays (Figure 5.2).  To determine if serum can cause 
inhibition of PCR, leading to false negative results, two dilution series from 
approximately 10,000 to approximately 0.1 organisms were assayed (Figure 5.3).  No 
significant inhibition was noted, as amplification was noted to a similar level 
(approximately one organism) regardless of the inclusion or exclusion of negative 
canine serum. 
 A real time PCR assay was developed as described and three identical dilution 
series of plasmids with insert were run in duplicate with 0.407 to 40,700 particles per 
reaction.  Negative and positive controls were included and amplified appropriately, 
notably negative controls did not indicate any significant DNA contamination (Figure 
5.4).  The concordance between the cycle threshold (Ct) values for each dilution 
predictably becomes weaker as the number of particles decreases, which is most 
notable at 0.4 and 4 particles (Figure 5.5).  The melt curve did not indicate the  
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Figure 5.4. Amplification plot with particles per reaction noted 
 
 
Figure 5.5: Standard curve for dilution series 
 
 
40,700 
4,070 
407 
40 
.4 
4 
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Figure 5.6: Melt curve 
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amplification of non-target DNA from samples or controls in any significant amount 
(Figure 5.6). 
  
DISCUSSION 
Though the sensitivity of detection of the Toxoplasma B1 gene versus 529 bp 
sequence was not directly compared in this study, B1 gene detection on this real-time 
platform was demonstrated to be sufficiently sensitive for use in diagnostic investigation.  
A recent reevaluation of copy numbers of both the B1 gene and the 529 b.p. sequence 
determined that the number of repeats of both had been overestimated in previous 
studies. This is likely due to earlier reliance on blotting as an adjunct to conventional 
PCR, though the 529 sequence was still noted to occur in greater numbers in the 
genome than the B1 gene (Costa and Bretagne, 2012).  The lack of detection of 
parasite DNA from serum samples is not surprising due to the nature of the parasite’s 
life cycle, in which DNA is only present in the intermediate host’s vascular system early 
in infection, demonstrated by detection in acute infection of 48.6% and in chronic 
infection of 3.6%.  Chronicity was characterized by the presence or absence of anti-
Toxoplasma IgM antibodies (Kompalic-Cristo et al., 2007).  In a study examining heart 
tissue from cattle, Toxoplasma DNA was detected in a small number of seronegative 
animals, with no seropositive animals testing positive (Opsteegh et al., 2011).  An 
investigation using quantitative real-time PCR for detection of the 529 bp element in 
various tissues from experimentally infected goats determined that the highest 
concentration of organism was found in lung tissue at 30 and 90 days post inoculation.  
Concentration of organism in the liver and dorsal muscle tissues increased with time, 
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whereas that in heart tissue decreased (Jurankova et al., 2012).  Of these, liver tissue is 
the most direct to sample antemortem, though sampling any of the organs  has the 
potential of serious complications. 
Further investigation into the utility of PCR for detection of Toxoplasma DNA and 
standardization of a protocol in the veterinary diagnostic setting is warranted.  These 
preliminary findings do not support the use of PCR in serologic diagnosis, but more 
study is needed.  The real time PCR results are promising for detection and predictable 
quantitation of parasite DNA based on Ct values for ≥ 40 organisms, though the 
significance of the latter information needs further investigation.  PCR has a more 
significant role in medical diagnostic investigation, though it has not replaced serological 
tests as the preferred first line method (Remington et al., 2004).  The life cycle of 
Toxoplasma, especially the transitory nature of its presence in the vascular system prior 
to tissue invasion complicates the use of PCR for diagnosis.  The method does have 
utility in distinguishing Toxoplasma oocysts from similar appearing oocysts when found 
by microscopy in feline feces.  In intermediate hosts where specific tissue invasion is 
suspected (e.g. ocular, neurological, fetal) due to the presence of pathognomonic 
clinical signs, PCR may be the most direct method to definitively establish etiology.  
Though commercial kits for PCR detection of Toxoplasma in tissue are available, 
comparison to the sensitivity of laboratory developed protocols seems to be 
unfavorable, possibly linked to the presence of PCR inhibitors in the samples (Morelle et 
al., 2012). The present study supports the feasibility of using PCR as a diagnostic 
method in veterinary investigation, while emphasizing the importance of acquiring 
appropriate tissue for the results to be clinically significant. 
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CHAPTER SIX 
CONCLUSION 
The development of an assay that can detect the presence of anti-Toxoplasma IgG 
antibody in serum samples from a broad range of animal species benefits veterinary 
and public health workers, both in identification of individual cases and characterization 
of the frequency of infection among different animal reservoirs. The recent cessation of 
production of commercial indirect hemagglutination and direct agglutination kits makes 
another option for veterinary diagnostic testing critical.  The substitution of protein A/G 
conjugate for the goat anti-human IgG conjugate included in the ELISA kit allows for 
testing across the range of animal species commonly tested.  Testing on this platform 
does not require the extended incubation periods of agglutination testing, nor the 
requirement for technicians to create a serial dilution of samples, as it is a single well 
test.  It is also a less subjective test, as optical density measurements are performed 
with a plate reader, rather than the tester interpreting the presence or absence and 
extent of agglutination visually.  Finally, the ready availability of domestically produced 
kits and protein conjugate avoids the prolonged importation process of previously used 
agglutination kits and components. 
Comparative testing utilized an Indirect Hemagglutination Assay (IHA) to initially 
test serum samples that had been submitted to the New York State Animal Health 
Diagnostic Center to detect anti-Toxoplasma IgG antibody.  Another aliquot of these 
samples was then retested using the ELISA technique with protein A, G or A/G 
horseradish peroxidase as the conjugate, depending upon the animal species from 
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which the serum was collected and which phase of the study was being conducted.  A 
comparison of IHA to ELISA testing using protein A for dog and cat serum and protein G 
for goat, horse, alpaca and sheep serum produced a Kappa value of 0.83 indicating 
very good agreement between the two tests, with a relative sensitivity of 90% and 
specificity of 95% for this group of samples.  A comparison of IHA to ELISA using 
chimeric protein A/G conjugate for all species tested produced a Kappa value of 0.81, 
with a relative sensitivity of 92% and specificity of 89%.  Disparate results between the 
two tests may be related to the underlying mechanism of detection, with ELISA requiring 
antibody to attach to antigen coated wells, whereas in indirect hemagglutination an 
antibody must be present in sufficient quantity to attach to antigen coated red blood 
cells to prevent agglutination.  Automation of testing and the use of avidity determination 
of infection chronicity are additional methods that make ELISA a more attractive 
technology for veterinary testing, methods that have been widely employed in medical 
testing. 
This newly developed ELISA allowed the rapid evaluation of a large number of 
serum samples from hunter-killed white-tailed deer across the state of New York in 
2010.  The prevalence in these deer was found to be 38.5%, with a 95% confidence 
interval of 31.2-45.8%, after correction for the ELISA test’s performance sensitivity and 
specificity.  Older deer (>1 year old) were found to have a significantly higher level of 
seroconversion than younger deer, providing insight into the greater significance of 
horizontal than vertical transmission in this population. No significant difference was 
noted in the level of male versus female exposure.  Similarly, no significant correlation 
was detected between the local human population density and the risk of seropositivity 
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in the hunter-killed deer.  Revisiting this question by including samples from deer killed 
in more densely populated areas of the state, for instance the Hudson Valley, will allow 
the opportunity to reevaluate this relationship.  Other studies noted an inverse 
relationship between human population density and deer infection, which may be due to 
an increased level of infection in rural cats, or a rural cat lifestyle that perpetuates the 
spread of oocysts more effectively.  Deer are a good sentinel for both Toxoplasma risk 
to other grazing animals of more economic significance (e.g. goats and sheep) and for 
the occurrence of oocysts in the local environment that also poses a risk to public 
health. 
Detection of Toxoplasma DNA in tissue samples by polymerase chain reaction is 
commonly performed on amniotic fluid from pregnant women suspected of infection and 
is increasingly available in veterinary diagnostic laboratories.  The most common targets 
are the B1 gene and the 529 base pair repeat element.  These were compared by 
traditional PCR with both published and newly developed primers to investigate their 
utility for quantitative real-time PCR detection.  Primers targeting the B1 gene were 
incorporated into a real-time assay, with cloned target used to investigate the detection 
limit of the assay and the reliability of quantitation.  Preparations of 40 or more target 
repeats produced accurate results, while those with four target repeats were detected 
as positive, but quantitation lacked precision.  This demonstrates the sensitivity of the 
assay, with cycle threshold values indicating 40 or more targets being useful for 
quantitation. The question of the usefulness of quantitation of Toxoplasma DNA in 
veterinary medicine remains open, though the demonstration of its significance in 
distinguishing severe from mild infection in humans is promising. The type of tissue 
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sampled for PCR is critical in interpreting any results, as well as affecting the sensitivity 
of the assay.  This was demonstrated by the lack of detection of DNA in serum samples 
from seropositive dogs and sheep in our study, suggesting serum as an inappropriate 
sample for testing. Testing blood samples from known acutely infected animals has a 
greater chance of detection, given that this is when tachyzoites are expected to be 
present in the vascular system. 
Toxoplasmosis remains a disease that causes consternation among both 
clinicians and diagnosticians.  The former due to its ability to produce a variety of clinical 
signs in a range of animal species, leading to its inclusion on numerous differential 
diagnoses lists, and the latter due to the non-specific nature of most serological test 
results and difficulty of acquiring appropriate tissue for molecular investigation.  The 
development of the above ELISA technique allows the continuation of serological 
testing for Toxoplasma exposure in the veterinary diagnostic setting, which has been 
compromised by the termination of production of some agglutination test kits.  Further 
development of this test to allow automation of the procedure and avidity detection will 
allow more efficient and informative results to be produced from a single sample.  The 
demonstration of accurate quantitation of copy numbers in a real-time PCR assay for 
the detection of the B1 gene target allows study to determine the significance in various 
tissue types to severity of the infection.  Acquiring the appropriate tissue to accomplish 
sensitive antemortem detection can be challenging, though whole blood, cerebrospinal 
fluid, muscle punch biopsies and aborted fetal tissue are accessible and appropriate 
depending on the stage and localization of infection.  The serosurvey of white-tailed 
deer from New York State demonstrates both the usefulness of the above described 
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ELISA technique and the potential of using deer studies to detect Toxoplasma in the 
environment.  This test and sentinel species both hold promise in advancing the 
understanding of the risks of this common parasite to animal and human health. 
 
 
 
 
 
 
 
